Walleye Capital LLC cut its stake in AVITA Medical, Inc. (NASDAQ:RCEL – Get Rating) by 14.2% in the second quarter, HoldingsChannel reports. The firm owned 13,657 shares of the company’s stock after selling 2,263 shares during the quarter. Walleye Capital LLC’s holdings in AVITA Medical were worth $65,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Simplex Trading LLC boosted its holdings in AVITA Medical by 2,093.3% in the first quarter. Simplex Trading LLC now owns 3,597 shares of the company’s stock valued at $30,000 after purchasing an additional 3,433 shares during the period. Russell Investments Group Ltd. purchased a new position in AVITA Medical in the first quarter valued at $30,000. Amalgamated Bank purchased a new position in AVITA Medical in the first quarter valued at $34,000. Granahan Investment Management LLC boosted its holdings in AVITA Medical by 18.6% in the first quarter. Granahan Investment Management LLC now owns 25,782 shares of the company’s stock valued at $219,000 after purchasing an additional 4,050 shares during the period. Finally, Rhumbline Advisers boosted its holdings in AVITA Medical by 23.3% in the first quarter. Rhumbline Advisers now owns 22,913 shares of the company’s stock valued at $194,000 after purchasing an additional 4,326 shares during the period. 20.75% of the stock is currently owned by hedge funds and other institutional investors.
AVITA Medical Price Performance
AVITA Medical stock opened at $7.39 on Monday. AVITA Medical, Inc. has a 1-year low of $4.41 and a 1-year high of $15.49. The stock has a market cap of $184.98 million, a PE ratio of -6.21 and a beta of 1.22. The stock’s fifty day moving average is $5.50 and its two-hundred day moving average is $5.75.
AVITA Medical Company Profile
AVITA Medical, Inc operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo.
- Get a free copy of the StockNews.com research report on AVITA Medical (RCEL)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for AVITA Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Medical and related companies with MarketBeat.com's FREE daily email newsletter.